Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

Renowned Cancer Researcher Named President of City of Hope National Medical Center and Physician-in-Chief of City of Hope

November 28, 2017 | City of Hope

Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.

Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma

November 17, 2017 | City of Hope

City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.

Researchers achieve remission using CAR T Cell therapy for aggressive brain tumors

February 15, 2017 | Denise Heady

City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR T cells dramatically improved quality of life for patient with recurrent glioblastoma.

Using CAR T cell immunotherapy to target glioblastomas

December 14, 2016 | Denise Heady

One of but a few centers in the United States offering human studies in CAR–T cell therapy, City of Hope is the only center investigating CAR T cells in injection form administered directly to brain tumors.

Clinical Trials Take CAR T Therapy to Patients Who Need It

December 14, 2016 | City of Hope

City of Hope has the clinical and scientific expertise to house the entire clinical trial process on its campus — including collecting the cells, manufacturing the lentivirus, modifying and replicating the cells and reinfusing them.

Study finds Triplex vaccine safe for use in healthy populations

December 14, 2016 | City of Hope

Data published in Blood supports ongoing phase 2 trial of Triplex in allogeneic hematopoietic stem cell transplant recipients.

Alliance Brings More Firepower to the Fight Against Cancer

December 1, 2016 | City of Hope

City of Hope joins forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and clinicians can convert research discoveries into cures.

Immunologist and diabetes chair leading new clinical trial aimed at curing type 1 diabetes

September 13, 2016 | By Letisia Marquez

Bart Roep, M.D., Ph.D., chair of City of Hope’s Department of Diabetes Immunology and an internationally recognized immunologist, is leading a clinical trial that just might lead to a cure for type 1 diabetes.

Gene therapy makes a potent weapon against against AIDS, cancer and more

August 11, 2016 | Jay Fernandez

This past year, leading-edge gene therapy has continued to take bold steps out of the laboratory and into the realm of potentially lifesaving treatments.

The role of B cells to target cancer's master switch

May 9, 2016 | City of Hope

In a study published in Immunity, scientists have unlocked a key component of STAT3 activation, a gene that has long been associated with tumor cell growth and anti-tumor immune suppression.